Looking for a trusted partner in the development of cell lines and manufacturing processes? Look no further. With over 20 years of experience, we specialize in high-yielding (5-14 g/L), GMP-ready, CHO, and HEK293 cell lines for the production of biologics, biosimilars, and gene therapy (AAV, Adenovirus).
We have a proven track record of expressing all types of proteins, including bi-specific mAb, Fc-fusions, viral proteins, cytokines, and more. Our team of scientists is ready to support your project from start to finish, including process development, analytical methods, scale-up, tox-batches, and Master Cell Banking.
At our company, we pride ourselves on our commitment to quality and customer satisfaction. Contact us today to see how we can help you achieve your goals and be your trusted partner in cell line and process development.

Biotechnology

Health Care

Life Sciences

Pharmaceutical

ExcellGene SA

Maria João Wurm

Divor Kiseljak

The Research and Development team at ExcellGene SA focuses on creating and optimizing high-yielding cell lines (CHO, HEK293) for the production of biologics, biosimilars, and gene therapies. This involves the development of cutting-edge processes, establishing analytical methods, and scaling up production from lab to GMP-ready levels. The team also manages tox-batches and Master Cell Banking, ensuring quality and efficiency in every step of the manufacturing process.

Research and Development

Operations and Management

Business Development

��

Research and Development

About

Team members

Other teams at ExcellGene SA

Operations and Management

Business Development

��������

Research and Development

About

Team members

Other teams at ExcellGene SA

Operations and Management

Business Development

��